HFS
RMD icon

Hantz Financial Services’s ResMed RMD Stock Holding History

Hantz Financial Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$796K Buy
4,086
+2,472
+153% +$512K 0.01% 576
2026
Q1 		$362K Buy
1,614
+558
+53% +$139K 0.01% 775
2025
Q4 		$254K Sell
1,056
-106
-9% -$27.1K ﹤0.01% 778
2025
Q3 		$318K Sell
1,162
-29
-2% -$7.92K ﹤0.01% 632
2025
Q2 		$307K Sell
1,191
-41,285
-97% -$9.85M 0.01% 568
2025
Q1 		$9.51M Sell
42,476
-1,658
-4% -$387K 0.17% 121
2024
Q4 		$10.1M Sell
44,134
-1,134
-3% -$273K 0.18% 125
2024
Q3 		$11.1M Sell
45,268
-1,341
-3% -$300K 0.2% 112
2024
Q2 		$8.92M Sell
46,609
-999
-2% -$203K 0.17% 148
2024
Q1 		$9.43M Sell
47,608
-2,340
-5% -$429K 0.18% 143
2023
Q4 		$8.59M Buy
49,948
+1,352
+3% +$208K 0.19% 156
2023
Q3 		$7.19M Sell
48,596
-2,730
-5% -$494K 0.18% 163
2023
Q2 		$11.2M Buy
51,326
+188
+0.4% +$41.9K 0.28% 106
2023
Q1 		$11.2M Buy
51,138
+861
+2% +$187K 0.31% 90
2022
Q4 		$10.5M Buy
50,277
+902
+2% +$198K 0.32% 95
2022
Q3 		$10.8M Buy
49,375
+216
+0.4% +$49.2K 0.37% 76
2022
Q2 		$10.3M Buy
49,159
+596
+1% +$127K 0.35% 84
2022
Q1 		$11.8M Buy
48,563
+2,810
+6% +$680K 0.35% 85
2021
Q4 		$11.9M Buy
45,753
+2,658
+6% +$690K 0.34% 85
2021
Q3 		$11.4M Buy
43,095
+4,900
+13% +$1.34M 0.37% 78
2021
Q2 		$9.42M Buy
38,195
+1,316
+4% +$277K 0.35% 81
2021
Q1 		$7.16M Buy
36,879
+1,298
+4% +$260K 0.3% 98
2020
Q4 		$7.56M Buy
35,581
+558
+2% +$111K 0.34% 79
2020
Q3 		$6M Buy
35,023
+642
+2% +$119K 0.31% 88
2020
Q2 		$6.6M Sell
34,381
-7,029
-17% -$1.15M 0.37% 72
2020
Q1 		$6.1M Buy
+41,410
New +$6.6M 0.42% 60

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hantz Financial Services's RMD Position: Q2 2026 in Review

Hantz Financial Services increased its ResMed (RMD) stake by 153% in Q2 2026, buying an estimated $512K and bringing the position to 4,086 shares worth $796K. The position accounts for 0.01% of the portfolio, ranked #576.

Hantz Financial Services first reported a position in RMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $11.9M in Q4 2021. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Hantz Financial Services held 4,086 shares of ResMed worth $796K as of Q2 2026.
  • Hantz Financial Services bought 2,472 ResMed shares in Q2 2026, an estimated $512K.
  • ResMed made up 0.01% of Hantz Financial Services's portfolio in Q2 2026, its #576 holding.
  • Hantz Financial Services first reported a position in ResMed in Q1 2020 and has held it in 26 quarters since.
  • Hantz Financial Services's ResMed position peaked at $11.9M in Q4 2021.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.